FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Dextrose Monohydrate 5% Injection
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Other; Pediatric

Expand all

Hospira, Inc., a Pfizer Company (Revised 12/03/2025)

Company Contact Information:
844-646-4398

Presentation	Posting Date	Related Information
Dextrose 5% In Plastic Container, Injection, 2.5 g/50mL (5%, 50mg/mL) (NDC 0409-7100-66)	12/03/2025	Discontinuation of the manufacture of the drug
Dextrose 5% In Plastic Container, Injection, 5 g/100mL (5%) Plastic (NDC 0409-7100-67)	12/03/2025	Discontinuation of the manufacture of the drug
Dextrose 5% In Plastic Container, Injection, 12.5 g/250mL (5%) (NDC 0409-7100-02)	12/03/2025	Discontinuation of the manufacture of the drug